The ATM kinase is a tumour suppressor and a key activator of genome integrity checkpoints in mammalian cells exposed to ionizing radiation (IR) and other insults that elicit DNA double-strand breaks (DSBs). In response to IR, autophosphorylation on serine 1981 causes dissociation of ATM dimers and initiates cellular ATM kinase activity. Here, we show that the kinetics and magnitude of ATM Ser1981 phosphorylation after exposure of human fibroblasts to low doses (2 Gy) of IR are altered in cells deficient in Nbs1, a substrate of ATM and a component of the MRN (Mre11-Rad50-Nbs1) complex involved in processing/repair of DSBs and ATMdependent cell cycle checkpoints. Timely phosphorylation of both ATM Ser1981 and the ATM substrate Smc1 after IR were rescued via retrovirally mediated reconstitution of Nbs1-deficient cells by wild-type Nbs1 or mutants of Nbs1 defective in the FHA domain or nonphosphorylatable by ATM, but not by Nbs1 lacking the Mre11-interaction domain. Our data indicate that apart from its role downstream of ATM in the DNA damage checkpoint network, the MRN complex serves also as a modulator/ amplifier of ATM activity. Although not absolutely required for ATM activation, the MRN nuclease complex may help reach the threshold activity of ATM necessary for optimal genome maintenance and prevention of cancer.
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Keywords: Nbs1; ATM; DNA damage; ionizing radiation; cell cycle checkpoints One of the hallmarks of cancer cells is their genetic instability, a feature associated with malfunction of cellular responses to DNA damage due to defective cell cycle checkpoints and/or DNA repair machinery. Among defects of such genome maintenance mechanisms known to predispose to cancer are mutations of ATM, Nijmegen breakage syndrome (NBS)1, and MRE11 genes that cause the chromosome instability syndromes ataxia-telangiectasia (A-T), NBS, and A-Tlike disease (A-TLD), respectively (Shiloh, 1997; Varon et al., 1998; Stewart et al., 1999) . The clinical resemblance of these diseases, their similar cellular phenotypes including radiation sensitivity and deficient checkpoint responses, as well as the accumulating functional evidence for the biological roles of the products of these genes suggest an intimate interplay of the ATM, Nbs1, and Mre11 proteins in cellular responses to DNA double-strand breaks (DSBs) (Shiloh, 1997; Petrini, 2000; Kastan and Lim, 2000; Lee et al., 2003; Shiloh, 2003) .
The nuclear protein kinase ATM becomes rapidly activated in response to ionizing radiation (IR) and other genotoxic insults that elicit DSBs, and it phosphorylates a wide range of proteins functionally implicated in the genome integrity network, including Nbs1 and Mre11 (Dong et al., 1999; Kim et al., 1999; Gatei et al., 2000; Lim et al., 2000) . Additional substrates of ATM encompass the checkpoint signalling kinases Chk2 and Chk1 (Ahn et al., 2000; Gatei et al., 2003; Matsuoka et al., 2000; Srensen et al., 2003) , checkpoint mediators BRCA1, 53BP1 and MDC1 (Anderson et al., 2001; Gatei et al., 2001; Lou et al., 2003; Okada and Ouchi, 2003) , histone H2AX, and diverse effectors of the DNA damage network involved in DNA repair, cell cycle, and cell death control, such as RAD9, RAD17, SMC1, FANCD2, p53 etc. (reviewed in Kastan and Lim, 2000; Shiloh, 2001 Shiloh, , 2003 .
The Nbs1 and Mre11 proteins are components of the so-called MRN complex (for the core subunits: Mre11, Rad50, and Nbs1) implicated in the early processing of DSBs via its DNA-binding and nuclease activities, contribution to DNA repair processes of homologous recombination and nonhomologous end joining, as well as participation in the intra-S phase and G2/M phase cell cycle checkpoints (D'Amours and Jackson, 2002; Thompson and Schild, 2002; Petrini and Stracker, 2003) . Whereas the checkpoint functions of the MRN complex lie downstream of ATM, being regulated by the ATM-mediated phosphorylations of Nbs1 (Shiloh, 2003) , the involvement of ATM in the accumulation of the MRN proteins at the sites of DNA damage seems less likely (Mirzoeva and Petrini, 2001 ). In addition, several studies of cellular responses to IR report suboptimal phosphorylation of some ATM targets in cells deficient in Nbs1 (Buscemi et al., 2001; Girard et al., 2002; Yazdi et al., 2002; Gatei et al., 2003; Lee et al., 2003) , indirectly suggesting a potential role of the MRN complex in modulating some aspect(s) of ATM function. Thus, despite both ATM and the MRN complexes playing critical early roles in response to DSBs and having been considered as candidate sensors of DNA damage (Petrini, 2000; Durocher and Jackson, 2001; Khanna and Jackson, 2001) , the exact temporal order and molecular basis of the interplay between ATM and MRN remain to be clarified. Elucidation of this important issue has so far been complicated, partly due to different experimental conditions used widely in previous studies, including different cellular models, doses of radiation, and the times, reagents and methods of evaluating the response to DSBs. Arguably most significantly, such studies suffered from the lack of a simple and validated approach to estimate the activity state of ATM. The latter drawback has recently been eliminated by the identification of an autophosphorylation on serine 1981 of ATM as the earliest detectable step of ATM activation (Bakkenist and Kastan, 2003) . Here, we employed the phosphospecific antibody against Ser1981-phosphorylated ATM (Bakkenist and Kastan, 2003) , and generated a model system allowing for the assessment of distinct functional domains of Nbs1 in identical cellular background of telomeraseimmortalized, Nbs1-deficient human fibroblasts, to gain further insights into the interplay between the MRN complex and ATM activity in response to IR.
To begin investigating the potential contribution of Nbs1 to ATM activation, we first exposed Nbs1-proficient, human diploid fibroblasts (the BJ strain) to low doses of IR. This strategy was chosen to avoid unpredictable adverse effects of cell transformation on the checkpoint kinetics, and to avoid the activation of redundant pathways by excessive DNA damage. After the exposure of asynchronously proliferating BJ cells to 2 Gy, ATM became rapidly activated as evidenced by its autophosphorylation on Ser1981. The magnitude of this effect was stabilized between 5 and 15 min after irradiation and begun to decline after additional 4 h ( Figure 1 ). Very similar kinetics was observed for the phosphorylation of several ATM-downstream targets including Ser966 of Smc1, Thr68 of Chk2 and Ser15 of p53 ( Figure 1 ; and data not shown). This rapid, quantitative and transient activation of the ATMdependent checkpoint response induced by low doses of IR was consistent with the recent mechanistic study of ATM activation (Bakkenist and Kastan, 2003) , and it indicated that our experimental system was sensitive enough to assess the kinetics of the ATM-dependent phosphorylation events.
Strikingly, when the same experimental protocol was applied on the human telomerase catalytic subunit (hTert)-immortalized NBS fibroblasts (NBS-Tert), ATM autoactivation was significantly impaired. Thus, the overall extent of Ser1981 autophosphorylation was weakened and it reached maximum only 1 h after irradiation (Figure 1) . Consistently, the kinetics of Smc1 phosphorylation was also delayed compared to the Nbs1-proficient BJ fibroblasts (Figure 1 ). These results were surprising and suggested that in addition to its well-established role as a genuine ATM substrate, Nbs1 may have an important role in the modulation of ATM activation in the IR-induced signalling cascade. To address this issue directly, we have generated a series of cellular models with distinct status of the Nbs1 protein.
Proper integration of Nbs1 into the IR-induced checkpoint signalling network depends on the integrity of several structural domains, phosphorylations, and protein-protein interactions (Desai-Mehta et al., 2001; Cerosaletti and Concannon, 2003; Lee et al., 2003) . To gain insight into whether and how these Nbs1 features determine its ability to modulate ATM activation, we reconstituted the NBS-Tert cells by retroviruses containing the wild-type (wt) and several mutant forms of human Nbs1 together with the gene coding for resistance to puromycin. Importantly, using the telomerase-immortalized cells eliminates the drawback of otherwise gross proliferative differences between the primary Nbs1-deficient cells and their Nbs1-reconstituted counterparts. The series of Nbs1 mutants included an inactivating point mutation within the FHA domain (R28/A), substitution of the ATM-targeted serines (S278, S343, S397) by alanines (3 Â S/A), and deletion of the Mre11-binding domain (Del628), respectively (Figure 2a ). Owing to cell-to-cell variation in expression levels of the Nbs1 proteins in the pooled cell populations, we selected puromycin-resistant clones homogeneously expressing the ectopic Nbs1 forms to nearphysiological levels (compared to the amount of protein in the Nbs1-proficient BJ cells) (Figure 2b ). All results obtained with these clones correlated well with experiments performed on the pooled cell populations (data not shown). While the wt, 3 Â S/A and Del628 forms of Nbs1 readily formed the IR-induced nuclear foci (IRIF), the cells reconstituted with the FHA-deficient R28/A or Lee et al., 2003) , and suggest that we succeeded to generate a relevant model system to study the impact of Nbs1 structural features on ATM activation.
Next, we subjected the above cell lines to the irradiation/time-course protocol as described in Figure 1 and assessed by immunoblotting with phosphospecific antibodies the kinetics of ATM autophosphorylation on S1981 together with phosphorylation of Smc1 on S966 (the latter was chosen as a model ATM substrate). Reconstitution of the NBS-Tert cells with wt Nbs1 restored the delayed kinetics of both ATM autoactivation and Smc1 phosphorylation (Figure 3 ) back to the profile typically observed in normal human fibroblasts (Figure 3 ; see also Figure 1 for comparison) . Specifically, in the Nbs1 wt-reconstituted cells, phosphorylations of ATM and Smc1 were detectable already in early time points (5-15 min) and begun to decline around 4 h after irradiation (Figure 3) . These results strongly supported our initial hypothesis that Nbs1 may modulate the timing and the amplitude of ATM activation in response to low doses of IR.
Interestingly, the three Nbs1 mutants showed differential effects on the kinetics of the studied ATM Figure 2 Reconstitution of Nbs1 expression in NBS-Tert fibroblasts. NBS cells containing the endogenous truncated and lowabundant form of Nbs1 (657del5) were infected with pBABE-puro vector alone, with the vector expressing myc-tagged Nbs1 wild-type (Nbs1 wt) or Nbs1 mutant forms (R28/A, 3 Â S/A, Del628) and grown in DMEM medium with 10% FBS, 100 U/ml penicillin, 100 mg/ ml streptomycin, and 1 mg/ml puromycin. The Phoenix A packaging cell line, grown in DMEM medium with 10% FBS, 100 U/ml penicillin, and100 mg/ml streptomycin, was transfected with the retroviral DNA by the calcium phosphate method and the NBS-Tert cells were infected as described (Pear et al., 1993; www. stanford.edu/group/nolan). The Nbs1 constructs were generated by site-directed mutagenesis with the use of QuickChange kit (Stratagene) (Falck et al., 2002) , myc-tagged, and inserted into the pBABE-puro vector (a). Adequate expression level of the constructs in selected clones was confirmed by immunoblotting (b). The ability to form foci after irradiation and to bind Mre11 were tested by immunofluorescence staining of the cells 8 h after irradiation with 10 Gy . The wild-type (Nbs1 wt) and the phosphorylation mutant of Nbs1 (3 Â S/A) bind Mre11 and form foci, mutation in the FHA domain (R28/A) affects foci formation while the deletion mutant (Del628) is able to form foci but cannot bind Mre11 (c) The antibodies used were: mouse monoclonal antibodies to human Mre11 (clone 12D7; GeneTex, San Antonio, TX, USA) and MCM7 (DCS-141, Srensen et al., 2000) , and rabbit polyclonal antibody against Nbs1 (Novus Biologicals, AB 398, Littleton, CO, USA). (d) The radiation sensitivity of the cells was estimated by colony-forming assay. The cells were exposed to 2 Gy of IR. After 2-3 weeks, colonies per plate were counted and expressed as the percentage of colonies seen in the unirradiated control. Data shown are the mean and standard deviation of three independent experiments, each performed in triplicate Nbs1 modulates ATM activation Z Hořejší et al phosphorylation events. Thus, the expression of the FHA-deficient Nbs1 (R28/A) completely rescued both ATM autoactivation and Smc1 phosphorylation defects inherent to the NBS-Tert cells (Figure 3 ). Since disruption of the FHA domain effectively abolished the accumulation of Nbs1 within IRIF (see Figure 2c ), it appears that the rate-limiting effect of Nbs1 on the ATM phosphorylation events does not require stable integration of Nbs1 into the chromosomal regions flanking the actual DNA breakage sites. In this regard, it is noticeable that a recent study reported that lack of detectable accumulation of checkpoint proteins in IRIF does not exclude their transient interaction with DSBs (Celeste et al., 2003) , a feature that might be necessary and sufficient for MRN to amplify ATM activity. Consistently, two recent reports demonstrated that the FHA-deficient Nbs1 restored timely ATM-dependent phopshorylation of Smc1 and Chk2, respectively (interestingly, this occurred despite the FHA-deficient Nbs1 itself was a poor ATM substrate and remained underphosphorylated) (Cerosaletti and Concannon, 2003; Lee et al., 2003) . Our present data add an important new dimension to these findings by showing that the restoration of ATM phosphorylation events (with or without the fully functional FHA domain) applies also to ATM autoactivation -in other words, to the very proximal and indeed the nodal point of the IR-induced signalling cascade. The phosphorylation-deficient mutant of Nbs1 (3 Â S/ A) also restored timely initiation of ATM activation and Smc1 phosphorylation, respectively (Figure 3 ). There is some discrepancy in the literature with regard to the requirement of Nbs1 phosphorylation for targeting various ATM substrates. Our results support those by Kim et al. (2002) , who also concluded that phosphorylation of Smc1 does not require preceding (or concomitant) Nbs1 phosphorylation. Moreover, these conclusions are also in line with the results obtained by several groups with the FHA-deficient Nbs1 (Cerosaletti and Concannon, 2003; Lee et al., 2003; this study) . Although this form of Nbs1 cannot be efficiently phosphorylated, it still supports timely phosphorylation of other ATM targets including Smc1 (see Figure 3) . Compared with the effects of wt and the FHA-deficient Nbs1, the NBS-Tert cells reconstituted with the phosphorylation-deficient Nbs1 (3 Â S/A) showed a moderately protracted phosphorylation of Smc1 in some experiments, suggesting a potential delay in exit from the activated checkpoint mode in such cells. Further validation of this observation and elucidation of its biological significance must await future studies.
Finally, the Nbs1 mutant deficient in binding to Mre11 (Del628) was completely unable to rescue the ATM autoactivation and, consequently, phosphorylation of the ATM-downstream targets such as Smc1 (Figure 3 ; and data not shown). As the Del628 mutant was readily integrated into IRIF, these data suggest that some Mre11-dependent function provided jointly by the MRN complex (likely the nuclease activity) is essential to promote rapid and massive activation of ATMdependent signalling.
Overall, our results (summarized in Table 1 ) support and extend several recent reports showing that Nbs1 (and/or other components of the MRN complex) may modulate phosphorylation kinetics of some ATMdownstream effectors. However, the above studies did not clarify whether this function of the MRN complex reflects its ability to convert the downstream checkpoint effectors into better substrates for ATM or whether this involves a direct influence on ATM activity. Our new data are consistent with the latter scenario and suggest that Nbs1, through its ability to interact with Mre11, Figure 3 Nbs1 modulates ATM activation after low doses of IR. Human NBS-Tert cells expressing different Nbs1 mutant forms and the cells infected with empty vector were irradiated with 2 Gy and lysed at the indicated times (5 min to 8 h) after irradiation. Phosphorylation of S1981 of ATM and S966 of SMC1 and the total level of SMC1 were examined by immunoblotting as described in Figure 1 Nbs1 modulates ATM activation Z Hořejší et al plays an important role in regulating the timing of the IR-induced, ATM-mediated phosphorylation events. After the completion of the experiments reported in this manuscript, broadly similar findings have been published by Shiloh and colleagues (Uziel et al., 2003) , who documented that the nuclease activity of Mre11 was required for the adequate activation of ATM in response to low doses of IR. The enzymatic activities of Mre11 involved in the initial resection and processing of DSBs (D'Amours and Jackson, 2002) may create some structural intermediate(s) that facilitate repair and signalling of DNA damage including the timely activation of ATM (Uziel et al., 2003; and this study) . This emerging proximal function of the MRN complex in response to DSB is likely independent of damageinduced phosphorylations, in contrast to its downstream function(s), mediated at least in part by the Smc1 checkpoint effector, which are dependent on ATMmediated phosphorylations (Yazdi et al., 2002; Kim et al., 2002) .
We believe that our present findings support and extend the recently proposed model of ATM activation (Bakkenist and Kastan, 2003) . According to this model, DSB induce local chromatin remodelling that, in turn, triggers transphosphorylation of the ATM dimers and their dissociation into activated monomers. We propose that especially after low doses of IR (when the ratelimiting effects of various inputs to ATM activation could be measured), the MRN complex plays an important role in amplifying this initial signal, thereby supporting timely and vigorous activation of multiple downstream effector pathways that cooperate to protect the genome against destabilizing effects of the DNA strand breaks. Given the widespread use of 'low-dose' radiation therapy in oncology, it is apparent that better understanding of ATM regulation including its functional interplay with the MRN complex may also help optimize treatment strategies and predict therapeutic responses in the future.
